✦ LIBER ✦

Focal therapy in the management of retinoblastoma: When to start and when to stop

✍ Scribed by Patrick Hamel; Andrew S. Budning; Elise Heon; Brenda L. Gallie

Book ID: 117847134
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 160 KB
Volume: 4
Category: Article
ISSN: 1528-3933
DOI: 10.1067/mpa.2000.107902

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trials: when to start and when

Clinical trials: when to start and when to stop

✍ Edmund Hey 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 42 KB

Managing Beta-blockers in Acute Heart Fa

Managing Beta-blockers in Acute Heart Failure: When to Start and When to Stop?

✍ Mehmet Birhan Yilmaz; Said Laribi; Alexandre Mebazaa 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 123 KB

Management of Favorable-Risk Patients Wi

Management of Favorable-Risk Patients With Metastatic Renal Cell Carcinoma: When to Start and When to Stop Targeted Therapy

✍ Thomas Powles; Peter Albers 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 273 KB

Molecularly targeted therapy: when to st

Molecularly targeted therapy: when to stop and when to continue?

✍ Fred R Hirsch; Tony S Mok; Virginia Borges; Paul A Bunn Jr 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 115 KB

When to start and when to stop primary p

When to start and when to stop primary prophylaxis in patients with severe haemophilia

✍ J. Astermark 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

**Summary.** Primary prophylactic treatment of patients with severe haemophilia has been shown to reduce the number of bleeding episodes and to minimize the development of arthropathy. However, since the use of clotting factor concentrates is associated with considerable cost and not all patients wi

Molecular methods in the diagnostic labo

Molecular methods in the diagnostic laboratory: when to start and where to stop

📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB